Daniel leads R&D Portfolio Strategy at Gilead Sciences, leveraging a Ph. D. from Harvard University to guide strategic and analytical decisions. His career includes progressive leadership roles at Takeda, focusing on pipeline and portfolio management. People who have worked with him describe him as knowledgeable, approachable, and reliable.
He maintains a strong interest in the academic and corporate pillars of the biotech world, including his alma mater, Harvard University, and the pioneering biotechnology company Genentech. This reflects a passion for both foundational research and its practical application in the industry.
His doctoral research included the "Structural, Nanomechanical, and Computational Characterization of d, l-Cyclic Peptide Assemblies, " highlighting a deep expertise in fundamental biochemistry.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.